In one of history’s most difficult financial environments, early-stage companies must look at new ways to secure funding. Connect has invited two speakers for this event. Jeff Stein, president and CEO of Trius Therapeutics, will provide a special case study that examines the series of financing mechanisms used to build Trius from its inception 2007 to the public company that it is today. Nikolay Savchuk, managing director of Torrey Pines Investment, will highlight the innovative aspects of the San Diego firm’s investment model. Registration at the door begins at 2:30, or register online here.